NCT00003585View on ClinicalTrials.gov

Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 31, 1996

Primary Completion Date

August 31, 2001

Study Completion Date

August 31, 2002

Conditions
Kidney Cancer
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

recombinant interferon alfa

DRUG

fluorouracil

DRUG

isotretinoin

PROCEDURE

surgical procedure

Trial Locations (1)

87131

University of New Mexico Cancer Research & Treatment Center, Albuquerque

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of New Mexico

OTHER

NCT00003585 - Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer | Biotech Hunter | Biotech Hunter